Moderna Inc (NASDAQ: MRNA) reportedly struck a deal with Chinese authorities to research, develop, and manufacture messenger RNA (mRNA) medicines in the country.
Allarity Therapeutics Inc (NASDAQ: ALLR) announced initial results from its European Phase 2 clinical trial evaluating the efficacy of Ixempra in metastatic breast cancer (mBC) patients selected with the DRP-Ixempra